Cargando…
Transformative hyaluronic acid-based active targeting supramolecular nanoplatform improves long circulation and enhances cellular uptake in cancer therapy
Hyaluronic acid (HA) is a natural ligand of tumor-targeted drug delivery systems (DDS) due to the relevant CD44 receptor overexpressed on tumor cell membranes. However, other HA receptors (HARE and LYVE-1) are also overexpressing in the reticuloendothelial system (RES). Therefore, polyethylene glyco...
Autores principales: | Zhong, Lu, Xu, Lu, Liu, Yanying, Li, Qingsong, Zhao, Dongyang, Li, Zhenbao, Zhang, Huicong, Zhang, Haotian, Kan, Qiming, Wang, Yongjun, Sun, Jin, He, Zhonggui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437598/ https://www.ncbi.nlm.nih.gov/pubmed/30972285 http://dx.doi.org/10.1016/j.apsb.2018.11.006 |
Ejemplares similares
-
Exploring the relationship of hyaluronic acid molecular weight and active targeting efficiency for designing hyaluronic acid-modified nanoparticles
por: Zhong, Lu, et al.
Publicado: (2019) -
Polydopamine-modified ROS-responsive prodrug nanoplatform with enhanced stability for precise treatment of breast cancer
por: Yang, Bin, et al.
Publicado: (2019) -
Multivalent
Ultrasensitive Interfacing of Supramolecular
1D Nanoplatforms
por: Magdalena Estirado, Eva, et al.
Publicado: (2019) -
Introducing Hyaluronic Acid into Supramolecular Polymers
and Hydrogels
por: Varela-Aramburu, Silvia, et al.
Publicado: (2021) -
Oxidation-strengthened disulfide-bridged prodrug nanoplatforms with cascade facilitated drug release for synergetic photochemotherapy
por: Yang, Bin, et al.
Publicado: (2020)